OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2023
(3)
2021
(2)
2026
(1)
2019
(1)
2024
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
"Ecce Homo" by Antonello da Messina, from non-invasive investigations to data fusion and dissemination.
Not available
S-EPMC8342594
|
biostudies-literature
Cite
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
Not available
S-EPMC6440108
|
biostudies-literature
Cite
Minimally invasive vs. open segmental resection of the splenic flexure for cancer: a nationwide study of the Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CNN).
Not available
S-EPMC9944710
|
biostudies-literature
Cite
CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma
Not available
S-SCDT-EMM-2020-12344
|
biostudies-other
Cite
Unraveling autophagic imbalances and therapeutic insights in Mecp2-deficient models
Not available
S-SCDT-10_1038-S44321-024-00151-W
|
biostudies-other
Cite
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.
Not available
S-EPMC13629653
|
biostudies-literature
Cite
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC10326520
|
biostudies-literature
Cite
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
Not available
S-EPMC10600726
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets